MORGAM Manual, Material and data transfer agreements

Material and Data Transfer Agreement (M&DTA) between the MORGAM Data Centre (MDC) at the National Institute for Health and Welfare (THL) and other MORGAM Centres: on the Use of Data for Research into the Epidemiology of Cardiovascular Disease Form: 53 Version: 1 Date: 17.10.2003

© National Institute for Health and Welfare and the MORGAM Project investigators Last updated: 28 March 2009 For more information, please contact Kari Kuulasmaa (firstname.lastname@thl.fi)

MORGAM is a multinational study of the epidemiology and genetics of cardiovascular disease morbidity and mortality. It is coordinated by Prof. Alun Evans, Department of Epidemiology and Public Health, Queen's University Belfast, in consultation with the MORGAM Management Group (MMG). The Project brings together DNA samples and phenotypic data from population cohorts in a number of countries; the samples and data in different countries have been collected by MORGAM Participating Centres (MPCs). The MORGAM Central Laboratory at the Department of Chronic Disease Prevention at THL collects DNA samples from MPCs, when necessary prepares DNA, undertakes genotyping and transfers aliquots of DNA to MORGAM Laboratories where further genotyping is carried out. The MORGAM Data Centre (MDC) at THL obtains phenotypic and genotypic data from the MPCs and MORGAM Laboratories, and provides phenotypic and genotypic data to MPCs and MORGAM Laboratories for data analysis.

The Department of Chronic Disease Prevention at THL hereby enters into a research collaboration with

________________________________________________________________

(hereafter called "the MORGAM Centre"). This agreement covers the transfer of genotypic and phenotypic data ("Data") from the MDC to the MORGAM Centre for analysis.

1. The parties mutually agree to carry out a Project called MORGAM (as defined above), which aims to publish high quality peer-reviewed papers.
2. A data analysis plan, including the approved Publication Proposal(s) and the details of the data, is given in Annex I of this Agreement.
3. The researchers additionally agree to the following conditions:
   • The Data can only be used for the analysis specified in the approved Publication Proposal(s) included in Annex I or in later approved Publication Proposals specifying the use of the Data.
   • The MORGAM Centre reports to the MMG on the progress of the data analysis at every meeting of the MMG, on completion of study and whenever reasonably requested by the MORGAM Coordinator or the Head of the MDC.
   • Upon completion of the data analysis for a publication, the MORGAM Centre will provide the MDC with a documentation of the analysis, including source code sufficient to permit repetition of the analysis and output listings of the results, which have been used in the manuscripts for publication.
   • Upon completion of the MORGAM Project or when requested by the MORGAM Coordinator or the Head of the MDC, the Data will be returned to the MDC, THL. Alternatively, if agreed with the MMG, the data can be destroyed, archived or sent to an MPC.
4. The MORGAM Publication rules will be followed for all publications derived from the Data (see  http://www.thl.fi/publications/morgam/manual/contents.htm).
5. The intellectual property rights concerning results derived from the data belong jointly to the MORGAM Centres (MPCs, MORGAM Laboratories and the MDC) that directly contributed to the results.
6. The MORGAM Centre undertakes to ensure that all persons dealing with the Data are familiar with this Agreement.

IN WITNESS WHEREOF the parties have executed this Agreement by their respective Officers hereunto duly authorized:

MORGAM Centre

Date:

Signature:

Printed name:

Position in organization:

Address:

THL/Department of Chronic Disease Prevention

Date:

Signature:

Printed name:

Position in organization:

Address:

A copy to be sent to each MPC concerned.

Updates to this form: